Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Genital Neoplasms, Male × BAY 86-7548 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Urogenital Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1 Breast Neoplasms 1

Interventions

Abiraterone Acetate 2 onapristone 1 olaparib 1 abiraterone 1 Pluvicto 1 EPI-506 1 BAY 86-7548 1 Androgen Antagonists 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02483884 2017-03-22

PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

Life Molecular Imaging SA

Phase 1/2 Terminated

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡